Frank Thomas
2020
In 2020, Frank Thomas earned a total compensation of $3M as President & COO at Orchard Therapeutics plc, a 100% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $105,750 |
|---|---|
| Option Awards | $2,399,615 |
| Salary | $469,693 |
| Other | $10,738 |
| Total | $2,985,796 |
Thomas received $2.4M in option awards, accounting for 80% of the total pay in 2020.
Thomas also received $105.8K in non-equity incentive plan, $469.7K in salary and $10.7K in other compensation.
Rankings
In 2020, Frank Thomas' compensation ranked 3,865th out of 13,090 executives tracked by ExecPay. In other words, Thomas earned more than 70.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,865 out of 13,090 | 71st |
Division Manufacturing | 1,538 out of 5,624 | 73rd |
Major group Chemicals And Allied Products | 582 out of 2,257 | 74th |
Industry group Drugs | 501 out of 1,957 | 74th |
Industry Biological Products, Except Diagnostic Substances | 118 out of 411 | 71st |
Source: SEC filing on April 28, 2021.
Thomas' colleagues
We found two more compensation records of executives who worked with Frank Thomas at Orchard Therapeutics plc in 2020.